XCUR CIK: 1698530

Exicure Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
43.7
FY22:
10.1
FY23:
2.02
FY24:
13.7
FY25:
4.62
(positive)
Change from FY21 to FY25
millions USD
FY21:
21.2
FY22:
13.3
FY23:
9.56
FY24:
1.38
FY25:
9.42
Total assets
Change from FY21 to FY25
millions USD
FY21:
64.9
FY22:
23.3
FY23:
11.6
FY24:
15.1
FY25:
14.0

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
34.1
FY22:
1.64
FY23:
2.51
FY24:
3.07
FY25:
3.89
(negative)
Change from FY21 to FY25
millions USD
FY21:
19.6
FY22:
6.77
FY23:
6.04
FY24:
5.21
FY25:
6.23
(positive)
Change from FY21 to FY25
millions USD
FY21:
11.2
FY22:
14.9
FY23:
3.03
FY24:
6.77
FY25:
3.93
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
64.9
FY22:
23.3
FY23:
11.6
FY24:
15.1
FY25:
14.0

All amounts in millions USD Data source:SEC EDGAR